Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Synthomer Plc LSE:SYNT London Ordinary Share GB0009887422 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.30 0.84% 155.40 155.10 155.70 155.80 142.60 142.60 1,153,431 15:43:19
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 2,329.5 283.9 48.3 3.2 726

Synthomer Share Discussion Threads

Showing 526 to 550 of 1225 messages
Chat Pages: Latest  25  24  23  22  21  20  19  18  17  16  15  14  Older
DateSubjectAuthorDiscuss
29/3/2022
08:23
I’m in. A very juicy dividend coming shortly.
robsy2
11/3/2022
16:41
As the statement says ExceptionalExceptionalExtraordinary Exceptional
the white house
11/3/2022
15:18
Is it really worth a long post of last year's figures when this year's finals were published a week ago?

Synthomer's market has changed significantly post-covid while the company is a different beast having acquired Eastman's business recently.

grahamburn
11/3/2022
13:22
...from last year...

Company overview:
Synthomer is a specialist chemical company and one of the world’s foremost suppliers of polymers. Headquartered in London, the company operates globally through more than 4000 employees across 38 sites. The company’s diversified portfolio of products serves customers in various sectors, such as adhesives, construction, textiles, energy, paper, coatings etc. In April last year they acquired OMNOVA solutions, a US based specialty chemical company. The transaction resulted in a global specialty chemicals specialty with significant scale. SYNT’s biggest benefit is probably  the material strength on the US market combined with penetration of the Chinese market, from the acquisition.
Growth is following a blended approach with several acquisitions over the last decade and constant investments in innovation. This is confirmed by the 20% of revenue arriving from products less than five years old.
The company’s portfolio provides a diversified exposure to various sectors, such as Health & Protection, Carpets, Paper, Adhesives, coating, Oil & Gas etc. Performance Elastomers and Functional solutions (OMNOVA CAST is dealing in the latter) brought around 80% of the revenue in 2020 with a total of $1.327bn. Markets where the Group operates are growing consistently and the acquisition of OMNOVA generated $30m of synergy savings run rate achieved by the end of 2020. The year saw record EBITDA at £259.4 million (45.8% growth) with 14% CAGR over the period 2014-2020.
Latest interim updated delivered sky high figures driven by strong demand for nitrile products, which are used in PPE for healthcare providers. The strong performance is based on the fact that the Group was part of an essential industry very early on in the pandemic, meaning their sites ran uninterrupted. The Performance Elastomers quadrupled cash profits and operational gearing went into overdrive. Working capital was affected by inflation in prices, but the demand outbalanced the price impact and kept WC/Total sales at 10%. The only thing which weakens the view is the impairment of £22.5m, but hey, we always said – if you are pursuing a growth through acquisitions strategy, brace yourself, as the fair value is rarely achieved in these transactions. Management expects normalized demand in Q3. Following the recent impairments, the outlook for these looks stress free, but we will monitor it closely as the intangibles account for £839m of the assets.

Short analysis:

Cash went up by 36%, from strong performance
Net debt positive as cash did not cover debt levels
CA/CL =  1.6
Cash ratio = 0.50
Interest coverage (FY 2020) =
P/S TTM= 1.08, which is way better than industry average
BV ps TTM = 190, growing at 16.1% CAGR
Operating profit for the interim was £288.6m, 4 times more than H1 2020...

...from WealthOracleAM

https://wealthoracle.co.uk/detailed-result-full/SYNT/91

km18
09/3/2022
13:52
Three NED buys in the last couple of days - first was just small change, then a reasonable c50k chunk and now a 614k position... hardly chicken feed! Hopefully their enthusiasm to load up indicates they also think this valuation is just plain silly...
le4r
03/3/2022
08:48
Crazily low valuation here now.
deadly
03/3/2022
08:27
Pleasing IMHO

Commenting, Michael Willome said:

"This has been an extraordinary year of outperformance for Synthomer. Record financial results alongside further strategic and operational progress is testament to the outstanding dedication of our employees, the strength of our portfolio and Synthomer's leading market positions globally. All areas of the business have had an excellent year, led by Performance Elastomers and unprecedented Nitrile latex demand due to the pandemic. We have taken full advantage of strong profits by acquiring Eastman's Adhesive Resins business and to support further investment in capacity, initiatives that will deliver significant benefits in the years ahead. With the market returning to more normalised growth conditions, the Group's prospects remain very attractive and we look forward to making progress in the year ahead."

james dean
03/3/2022
08:09
Intrigued by the headlines of morning's FY results, and the forecast trajectory. The PI World video (post #535) is a great briefing, form 26 - 47 minutes, especially the last half, tightfist
tightfist
14/1/2022
18:35
Cyclical stock, fear of reduction on PPE contract
hatfullofsky
14/1/2022
14:04
surprised by how low this keeps going, as a holder i dont quite follow the rationale here.
dippydodaa
14/1/2022
09:33
Daniel Jones Pitches #SYNT in the latest episode of PIWORLD's Sell it to the City.

Daniel Jones pitches Synthomer (SYNT) to Andy Brough, Schroders, Judith MacKenzie, Downing and Stephen English, Stellar Asset Management in the second episode of PIWORLD's Sell it to the City.

Watch the video here: Https://www.piworld.co.uk/education-videos/piworld-sell-it-to-the-city-january-2022/

Or listen to the podcast here: Https://piworld.podbean.com/e/piworld-sell-it-to-the-city-january-2022/

tomps2
11/1/2022
19:06
I agree with your thinking.
james dean
11/1/2022
18:46
Well, I'm in now. Think we'll see a little bounce on the trading update followed by a rise back to the old trend line
hatfullofsky
17/12/2021
09:58
PIWORLD interview with Richard Leonard: Winners and Losers of 2021

02:24 What went badly: Synthoma #SYNT

Video: Https://www.piworld.co.uk/education-videos/piworld-interview-with-richard-leonard-winners-and-losers-of-2021/

tomps2
07/12/2021
11:50
Predictable bounce today but still much further to go.
deadly
07/12/2021
07:57
https://www.fool.co.uk/2021/12/06/why-is-the-synthomer-lsesynt-share-price-down-14-today/
tole
06/12/2021
14:28
MS clients obviously didn't get as many shares as they wanted.
podgyted
06/12/2021
14:01
Institutional Placing at 485p just over a month ago?
libertine
06/12/2021
10:04
I suppose looking at the one year chart you could say with hindsight that a pull back to around 433p was inevitable. Probably next year there is going to be the oversupply of nitrile that was threatened pre-Covid. The whole point of the Eastman acquisition though is to dilute the effect of the end of the nitrile superprofits. I can see potential for bumpier trading conditions next year but I think SYNT remains a great long-term investment.
kinwah
06/12/2021
09:51
Just bought - MS say 400p today, Canacorrd said 750p last week. Happy to go in at 433.
chris79
06/12/2021
09:47
Double downgrade on non-specific news seems a little opportunistic to me. Wouldn't be surprised to see massive buying later once they got it down to their target price. Hound Partners also probably looking to fully close their short position which is now below 0.5%.
ppreston1
06/12/2021
09:18
Morgan Stanley double downgrade this morning price target 400p
libertine
06/12/2021
09:16
No significant movement elsewhere in the sector, if anything they are mostly up today. I have noted the lack of a q3 trading update, was one in October last year
texaspete2
06/12/2021
09:11
Morgan Stanley cut to underweight could be responsible.
clanger66
06/12/2021
09:07
No idea. Anyone in this sector reporting?
kevph
Chat Pages: Latest  25  24  23  22  21  20  19  18  17  16  15  14  Older
Your Recent History
LSE
SYNT
Synthomer
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230131 15:59:03